Visceral fat and bevacizumab in metastatic colorectal cancer Response

被引：0
|
作者：
Bonnetain, F. [2 ,3 ]
Guiu, B. [4 ,5 ]
Ghiringhelli, F. [1 ,5 ]
机构：
[1] Georges Francois Leclerc Canc Ctr, Dept Oncol, Dijon, France
[2] Georges Francois Leclerc Canc Ctr, Biostat & Epidemiol Unit, Dijon, France
[3] Sch Med, Dijon, France
[4] CHU Univ Hosp, Dept Radiol, Dijon, France
[5] Univ Burgundy, INSERM, Dijon, France
来源：
GUT | 2010年 / 59卷 / 10期
关键词：
PROGRESSION-FREE SURVIVAL;
D O I：
10.1136/gut.2010.220434
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1450 / 1450
页数：1
相关论文
共 50 条
  • [21] FOLFOXIRI plus Bevacizumab in metastatic colorectal Cancer
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (07): : 630 - 630
  • [22] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Benedik, Jernej
    Volk, Neva
    ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [23] Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
    Tol, Jolien
    Koopman, Miriam
    Cats, Annemieke
    Rodenburg, Cees J.
    Creemers, Geert J. M.
    Schrama, Jolanda G.
    Erdkamp, Frans L. G.
    Vos, Allert H.
    van Groeningen, Cees J.
    Sinnige, Harm A. M.
    Richel, Dirk J.
    Voest, Emile E.
    Dijkstra, Jeroen R.
    Vink-Borger, Marianne E.
    Antonini, Ninja F.
    Mol, Linda
    van Krieken, Johan H. J. M.
    Dalesio, Otilia
    Punt, Cornelis J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06): : 563 - 572
  • [24] Chemotherapy With Bevacizumab for Advanced or Metastatic Colorectal Cancer
    Hirata, Masaru
    GASTROENTEROLOGY, 2014, 146 (05) : S694 - S694
  • [25] SAFETY PROFILE OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Castillo, M. A.
    Ubago, R.
    Flores, S.
    Rodriguez, R.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A437 - A437
  • [26] BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: MOROCCAN CHALLENGE
    Mouzount, H.
    Allam, W.
    Errihani, H.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [27] Bevacizumab Maintenance in Metastatic Colorectal Cancer Reply
    Aparicio, Thomas
    Ghiringhelli, Francois
    Boige, Valerie
    Le Malicot, Karine
    Taieb, Julien
    Bennouna, Jaafar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (23) : 2452 - +
  • [28] Influence of Visceral Fat in the Outcomes of Colorectal Cancer
    Goulart, Andre
    Malheiro, Nuno
    Rios, Hugo
    Sousa, Nuno
    Leao, Pedro
    DIGESTIVE SURGERY, 2019, 36 (01) : 33 - 40
  • [29] Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer
    Aravantinos, G.
    Isaakidou, A.
    Karantanos, T.
    Sioziou, A.
    Theodoropoulos, G. E.
    Pektasides, D.
    Gazouli, M.
    CANCER BIOMARKERS, 2015, 15 (06) : 843 - 850
  • [30] Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
    Toshiaki Takahashi
    Kunitoshi Shigeyasu
    Yoshitaka Kondo
    Sho Takeda
    Hibiki Umeda
    Kazuya Moriwake
    Masashi Kayano
    Yuya Sakurai
    Shunsuke Nakamura
    Masafumi Takahashi
    Kaori Nitta
    Kazuhiro Yoshida
    Yuki Matsumi
    Hiroyuki Michiue
    Hideki Yamamoto
    Hiroyuki Kishimoto
    Fuminori Teraishi
    Ryohei Shoji
    Nobuhiko Kanaya
    Hajime Kashima
    Yoshihiko Kakiuchi
    Shinji Kuroda
    Shunsuke Kagawa
    Toshiyoshi Fujiwara
    BMC Cancer, 25 (1)
12345